SS Innovations Reports Third Quarter 2025 Financial Results

SS Innovations International, Inc. announced its unaudited financial results for the third quarter of 2025, showing a significant increase in revenue and gross profit. The company reported a 192.5% year-over-year increase in revenue, reaching $12.8 million, driven by higher sales of its SSi Mantra 3 surgical robotic system. Gross profit rose by 166.0% to $6.2 million, although the gross margin decreased slightly to 48.1% from 52.8% in the same period last year. The company also reported a net loss of $3.7 million, or $(0.02) per diluted share, compared to a net loss of $3.2 million, or $(0.02) per diluted share, in the third quarter of 2024. SS Innovations highlighted the successful completion of several key milestones, including the first robotic telesurgery and the world’s first pediatric pyeloplasty telesurgery using the SSi Mantra system. The company is also making progress towards regulatory approvals in the U.S. and European Union markets.